The standard BPC-157 dosage is 250-500 mcg injected subcutaneously once or twice daily for 4-8 weeks, adjusted for injury type, body weight, and reconstitution concentration
Preclinical studies in rodents with long-acting GIP, GLP-1, and GLP-2 analogues, alongside related clinical trials, suggest these molecules are safe, and furthermore, may improve overall bone health
If you have symptoms like nausea, vomiting, fever, or abdominal pain, get medical help
We offer a diverse treatment menu, ranging from the popular Myers Cocktail to innovative NAD+ therapy
Weekly injectable GLP-1 medications can be administered at any time of day, provided it's consistent from week to week